Pharming Group NV (PHAR)
16.13
+0.14
(+0.88%)
USD |
NASDAQ |
Mar 03, 14:08
Pharming Group Enterprise Value : 1.060B for March 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| uniQure NV | 491.48M |
| ProQR Therapeutics NV | 58.00M |
| argenx SE | 46.76B |
| Pharvaris NV | 1.433B |
| NewAmsterdam Pharma Co. NV | 3.137B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 7.466M |
| Revenue (Quarterly) | 96.86M |
| Total Expenses (Quarterly) | 89.39M |
| EPS Diluted (Quarterly) | 0.109 |
| Gross Profit Margin (Quarterly) | 92.70% |
| Profit Margin (Quarterly) | 7.71% |
| Earnings Yield | 0.09% |
| Operating Earnings Yield | 3.09% |
| Normalized Earnings Yield | 0.7477 |